Randomized, double-blind, parallel-group, 48-week study for efficacy and safety of a higher-dose rivastigmine patch (15 vs. 10 cm²) in Alzheimer's disease. (Q48439989)
Jump to navigation
Jump to search
scientific article published on 11 July 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Randomized, double-blind, parallel-group, 48-week study for efficacy and safety of a higher-dose rivastigmine patch (15 vs. 10 cm²) in Alzheimer's disease. |
scientific article published on 11 July 2012 |
Statements
1 reference
Randomized, double-blind, parallel-group, 48-week study for efficacy and safety of a higher-dose rivastigmine patch (15 vs. 10 cm²) in Alzheimer's disease. (English)
1 reference
1 reference
1 reference
1 reference
Jeffrey Cummings
1 reference
Lutz Froelich
1 reference
Serge Bakchine
1 reference
Reto W Kressig
1 reference
Pamela Downs
1 reference
Angelika Caputo
1 reference
Christine Strohmaier
1 reference
11 July 2012
1 reference
33
1 reference
5
1 reference
341-353
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference